Spirit Scientific Co., Ltd.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Spirit Scientific Co., Ltd. has developed a platelet dry powder manufacturing technology, patent number I480066. Utilizing a pharmaceutical-grade concept of standardized dosage and quantification, this technology isolates platelets with a well-defined concentration and subjects them to purification and protection procedures. Vacuum freeze-drying technology is then applied to thoroughly remove moisture and impurities from the high-concentration lyophilized platelet finished product, yielding a long-term storable PLT (Platelet Lyophilized Treatment) finished product.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83234460
Status
Active
Number of Employees
0
Total Paid-in
Capital
185,846,680 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
Emerging Stock Exchange(2024)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in 2015, Spirit Scientific Co., Ltd. provides high-efficiency and stable preparations that promote self-healing, as well as biomaterial lyophilization preparation services, through the establishment of its own cleanroom laboratories, patented technologies, and the construction of innovative service models. After years of deep cultivation in the precision regenerative medicine market, Spirit Scientific Co., Ltd. has become a leading brand in platelet lyophilization technology.
Spirit Scientific Co., Ltd. has further pioneered the use of Biofoundry™ and pharmaceutical-grade specifications to develop BMLT (Bio Material Lyophilized Technology) biomaterial lyophilization technology, starting from the extraction of high-concentration platelet growth factors and developing the optimal freeze-drying process tailored to the characteristics of different biomaterials. We continue to develop diverse related applications to rewrite the industry rules of precision regenerative medicine.
Our team possesses a forward-looking vision and rich experience, successfully converting patented technologies into business models and collaborating with thousands of medical institutions to provide new treatment options that are fixed-dose and quantitative, safe and reliable, flexibly applicable, and storable at room temperature for the long term, allowing physicians and patients to realize the immense potential of platelets.
In addition to promoting preparation services such as autologous high-concentration platelet lyophilization, Spirit Scientific Co., Ltd. also accepts business cooperation models such as CDMO and OEM/ODM.
(The content above was translated by AI.)
Spirit Scientific Co., Ltd. has further pioneered the use of Biofoundry™ and pharmaceutical-grade specifications to develop BMLT (Bio Material Lyophilized Technology) biomaterial lyophilization technology, starting from the extraction of high-concentration platelet growth factors and developing the optimal freeze-drying process tailored to the characteristics of different biomaterials. We continue to develop diverse related applications to rewrite the industry rules of precision regenerative medicine.
Our team possesses a forward-looking vision and rich experience, successfully converting patented technologies into business models and collaborating with thousands of medical institutions to provide new treatment options that are fixed-dose and quantitative, safe and reliable, flexibly applicable, and storable at room temperature for the long term, allowing physicians and patients to realize the immense potential of platelets.
In addition to promoting preparation services such as autologous high-concentration platelet lyophilization, Spirit Scientific Co., Ltd. also accepts business cooperation models such as CDMO and OEM/ODM.
(The content above was translated by AI.)
